These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33273509)

  • 1. Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening.
    Kumar S; Jang C; Subedi L; Kim SY; Kim MH
    Sci Rep; 2020 Dec; 10(1):21133. PubMed ID: 33273509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repackaging FDA-approved drugs for degenerative diseases: promises and challenges.
    Cummings JL; Zhong K
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):161-5. PubMed ID: 24502586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting Profiles.
    Battah B; Chemi G; Butini S; Campiani G; Brogi S; Delogu G; Gemma S
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31795400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing.
    Lim H; Poleksic A; Yao Y; Tong H; He D; Zhuang L; Meng P; Xie L
    PLoS Comput Biol; 2016 Oct; 12(10):e1005135. PubMed ID: 27716836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new computational drug repurposing method using established disease-drug pair knowledge.
    Saberian N; Peyvandipour A; Donato M; Ansari S; Draghici S
    Bioinformatics; 2019 Oct; 35(19):3672-3678. PubMed ID: 30840053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform.
    Chopra G; Samudrala R
    Curr Pharm Des; 2016; 22(21):3109-23. PubMed ID: 27013226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docking-based virtual screening of known drugs against murE of Mycobacterium tuberculosis towards repurposing for TB.
    Brindha S; Sundaramurthi JC; Velmurugan D; Vincent S; Gnanadoss JJ
    Bioinformation; 2016; 12(8):359-367. PubMed ID: 28275291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential.
    Lo YC; Senese S; France B; Gholkar AA; Damoiseaux R; Torres JZ
    Sci Rep; 2017 Sep; 7(1):11261. PubMed ID: 28900159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognizing drug targets using evolutionary information: implications for repurposing FDA-approved drugs against Mycobacterium tuberculosis H37Rv.
    Ramakrishnan G; Chandra NR; Srinivasan N
    Mol Biosyst; 2015 Dec; 11(12):3316-31. PubMed ID: 26429199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
    Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing of existing FDA approved drugs for Neprilysin inhibition: An
    Sankhe R; Rathi E; Manandhar S; Kumar A; Pai SRK; Kini SG; Kishore A
    J Mol Struct; 2021 Jan; 1224():129073. PubMed ID: 32834116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
    Kumar S; Chowdhury S; Kumar S
    BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Gurung AB
    Gene Rep; 2020 Dec; 21():100860. PubMed ID: 32875166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring anti-malarial potential of FDA approved drugs: an in silico approach.
    Ramakrishnan G; Chandra N; Srinivasan N
    Malar J; 2017 Jul; 16(1):290. PubMed ID: 28720135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rings in drugs.
    Taylor RD; MacCoss M; Lawson AD
    J Med Chem; 2014 Jul; 57(14):5845-59. PubMed ID: 24471928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
    Konreddy AK; Rani GU; Lee K; Choi Y
    Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target.
    DurdaĞi S
    Turk J Biol; 2020; 44(3):185-191. PubMed ID: 32595355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Repurposing from an Academic Perspective.
    Oprea TI; Bauman JE; Bologa CG; Buranda T; Chigaev A; Edwards BS; Jarvik JW; Gresham HD; Haynes MK; Hjelle B; Hromas R; Hudson L; Mackenzie DA; Muller CY; Reed JC; Simons PC; Smagley Y; Strouse J; Surviladze Z; Thompson T; Ursu O; Waller A; Wandinger-Ness A; Winter SS; Wu Y; Young SM; Larson RS; Willman C; Sklar LA
    Drug Discov Today Ther Strateg; 2011; 8(3-4):61-69. PubMed ID: 22368688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA Approved Drugs Repurposing of Toll-Like Receptor4 (TLR4) Candidate for Neuropathy.
    Zali H; Golchin A; Farahani M; Yazdani M; Ranjbar MM; Dabbagh A
    Iran J Pharm Res; 2019; 18(3):1639-1647. PubMed ID: 32641971
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Gurung AB; Ali MA; Lee J; Abul Farah M; Al-Anazi KM
    Saudi J Biol Sci; 2020 Oct; 27(10):2674-2682. PubMed ID: 32837219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.